Bengaluru, October 30, 2018: Artificial intelligence-based health-tech company Niramai is set for a national expansion with three breast cancer screening centres in Hyderabad, Mysore and Mumbai. In Hyderabad, Niramai offers exclusive breast cancer screening centre in Lumbini Jewel mall. While, in Mysore and Mumbai it has collaborated with Brindavan Hospital and Way2Health Diagnostics respectively.
The breast health screening technology developed by Niramai is unique as it is non-touch, non-invasive and non-radiation based. Their privacy-aware test for preventive breast cancer screening that was available only in Bangalore, Pune and Dehradun is expanding its reach to multiple cities.
The core technology developed by Niramai called Thermalytix, uses a high resolution thermal sensing device and a cloud hosted analytics solution for analyzing the thermal images. Their SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in Niramai’s solution have led to multiple US patents and their novel algorithms have also been peer-reviewed in international scientific conferences. Niramai’s technology detects breast cancer at a much earlier stage than traditional methods or self-examination.
Dr Geetha Manjunath, CEO & CTO, Niramai, said, “Accessibility to high quality preventive care is critical to reduce breast cancer deaths in the country. We believe this can be achieved through partnership and collaboration. Our goal is to enable regular breast health check for all women in India in an affordable and accessible way”.
In Hyderabad, Niramai unveiled first of a kind exclusive breast cancer screening centre in partnership with Murata Business Engineering (India) Pvt Ltd (MBEI) and Big Edge Solutions & Technology India Pvt Ltd. This health centre, named UmAnG, is situated in Lumbini Jewel mall and will be a boon to women who want to be sure of their breast health in a friendly environment without having to visit a hospital for the same.
Dr Karun Malhotra, Managing Director, MBEI, said, "We focus on healthcare solutions using electronics as a platform that are reliable, easy to use, affordable and digital. Niramai’s solution has all these advantages, and they have a great vision to transform the adoption of breast cancer screenings. Big Edge Solutions team has shown exemplary commitment towards execution of the vision of the first UmAnG center in Hyderabad”.
Dr Ravindranath K, Director, Brindavan Hospital, Mysore, said, “We are happy to associate with Niramai. The cutting edge technology of Niramai gives accurate and fast screening reports and is privacy aware”.
Dr. Rachna Tardeja, Consultant Radiologist & Founder Director, Way2Health Diagnostics, Mumbai, said, “We are excited to partner with Niramai to make breast cancer screening easily accessible to all women, since it is non-touch and non-invasive, who otherwise generally shy away from it”.
Niramai was co-founded in the year 2016 by Dr Geetha Manjunath and Nidhi Mathur, both of who have vast experience in developing disruptive innovations for Indian as well as global markets. In 2017, they raised seed funding led by pi Ventures, with participation from Ankur Capital, Axilor Ventures, 500 Startups and Flipkart co-founder Binny Bansal.